# CADL (Candel Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Candel Therapeutics, Inc. reported $211.1M in total assets and a net loss of $99.14M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CADL
- Markdown: https://convexityos.com/fundamentals/CADL.md
- SEC CIK: 0001841387
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001841387&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$81.76M | Operating profit |
| Net Income | FY 2025 | -$99.14M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.28 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$70.20M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $203.1M | Total debt: $1.57M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $125K | $125K | $125K |
| Research & Development | $30.50M | $19.31M | $24.51M | $20.79M | $15.18M | $8.75M |
| Total Operating Expenses | $48.27M | $33.37M | $38.39M | $34.85M | $25.85M | $13.94M |
| **Operating Income** | -$48.27M | -$33.37M | -$38.39M | -$34.72M | -$25.73M | -$13.81M |
| **EBITDA** | -$47.42M | -$32.38M | -$37.43M | -$33.94M | -$25.49M | -$13.72M |
| Interest Income | -- | -- | $2.08M | $1.22M | -- | -- |
| Interest Expense | $2.12M | $2.09M | -$2.60M | $1.71M | -- | -- |
| Income Before Tax | -$38.18M | -$55.18M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | -$38.18M | -$55.18M | -$37.94M | -$18.79M | -$36.12M | -$17.68M |
| Basic EPS | -$0.72 | -$1.74 | -$1.31 | -$0.65 | -$1.91 | -$1.52 |
| **Diluted EPS** | -$0.72 | -$1.74 | -$1.31 | -$0.65 | -$1.91 | -$1.52 |
| Basic Shares Outstanding | 53.0M | 31.7M | 28.9M | 28.8M | 18.9M | 11.6M |
| Diluted Shares Outstanding | 53.0M | 31.7M | 28.9M | 28.8M | 18.9M | 11.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $15.59M | $19.80M | $9.84M | $11.03M | $8.46M | $6.99M | $4.02M | $4.82M |
| Total Operating Expenses | $22.98M | $26.75M | $16.28M | $15.75M | $13.21M | $11.18M | $8.13M | $8.14M |
| **Operating Income** | -$22.98M | -$26.75M | -$16.28M | -$15.75M | -$13.21M | -$11.18M | -$8.13M | -$8.14M |
| **EBITDA** | -$22.78M | -$26.55M | -$16.14M | -$15.59M | -$13.01M | -$10.98M | -$7.88M | -$7.90M |
| Interest Expense | $1.59M | $1.57M | $1.56M | $1.42M | $161K | $236K | $306K | $390K |
| **Net Income** | -$21.87M | -$38.91M | -$8.86M | -$29.50M | -$11.27M | -$4.80M | $7.38M | -$14.07M |
| Basic EPS | -$0.28 | -$0.52 | -$0.14 | -- | -$0.21 | -$0.09 | $0.15 | -- |
| **Diluted EPS** | -$0.28 | -$0.52 | -$0.14 | -- | -$0.21 | -$0.09 | $0.13 | -- |
| Basic Shares Outstanding | 77.4M | 74.1M | 62.4M | -- | 54.9M | 51.5M | 50.5M | -- |
| Diluted Shares Outstanding | 77.4M | 74.1M | 62.4M | -- | 54.9M | 51.5M | 54.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $119.7M | $102.7M | $35.41M | $70.06M | $82.64M | $35.05M |
| **Cash & Short-Term Investments** | $119.7M | $102.7M | $35.41M | $70.06M | $82.64M | $35.05M |
| **Total Current Assets** | $121.4M | $103.8M | $36.80M | $71.94M | $84.94M | $35.15M |
| Property, Plant & Equipment, Net | $1.64M | $2.19M | $3.21M | $4.42M | $3.84M | $2.79M |
| Other Non-Current Assets | -- | -- | -- | -- | $424K | $349K |
| **Total Non-Current Assets** | $3.81M | $3.06M | $4.40M | $5.75M | $4.26M | $3.14M |
| **Total Assets** | $125.2M | $106.9M | $41.20M | $77.69M | $89.20M | $38.28M |
| Accounts Payable | $1.13M | $237K | $422K | $380K | $1.59M | $921K |
| Short-Term Debt | $0 | $9.89M | $8.89M | -- | -- | -- |
| Other Current Liabilities | $89K | $0 | -- | $48K | $334K | $187K |
| **Total Current Liabilities** | $9.00M | $37.53M | $14.18M | $5.62M | $5.36M | $4.71M |
| Long-Term Debt | -- | $1.73M | $11.63M | -- | $560K | $483K |
| Deferred Revenue (Non-Current) | $89K | $0 | -- | $144K | -- | $125K |
| **Total Non-Current Liabilities** | $64.28M | $3.01M | $14.27M | $24.36M | $19.71M | $8.07M |
| **Total Liabilities** | $73.27M | $40.54M | $28.46M | $29.98M | $25.07M | $12.78M |
| **Total Debt (incl. Leases)** | $1.90M | $12.60M | $22.01M | $1.95M | $560K | $483K |
| Common Stock | $550K | $469K | $290K | $290K | $286K | $116K |
| Retained Earnings | -$230.4M | -$192.2M | -$137.0M | -$99.09M | -$80.30M | -$44.17M |
| **Total Stockholders' Equity** | $51.92M | $66.33M | $12.74M | $47.71M | $64.14M | -$23.56M |
| Total Equity | $51.92M | $66.33M | $12.74M | $47.71M | $64.14M | -$23.56M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $203.1M | $201.6M | $194.8M | $119.7M | $86.96M | $100.7M | $92.17M | $102.7M |
| **Cash & Short-Term Investments** | $203.1M | $201.6M | $194.8M | $119.7M | $86.96M | $100.7M | $92.17M | $102.7M |
| **Total Current Assets** | $207.4M | $204.2M | $197.8M | $121.4M | $90.13M | $103.6M | $93.15M | $103.8M |
| Property, Plant & Equipment, Net | $1.90M | $2.00M | $2.08M | $1.64M | $1.36M | $1.66M | $1.97M | $2.19M |
| **Total Non-Current Assets** | $3.76M | $3.99M | $4.17M | $3.81M | $3.46M | $2.36M | $2.76M | $3.06M |
| **Total Assets** | $211.1M | $208.1M | $201.9M | $125.2M | $93.60M | $106.0M | $95.91M | $106.9M |
| Accounts Payable | $2.54M | $5.15M | $3.04M | $1.13M | $1.12M | $1.95M | $760K | $237K |
| Short-Term Debt | -- | -- | -- | $0 | $4.22M | $6.70M | $9.17M | $9.89M |
| Other Current Liabilities | $89K | $89K | $89K | $89K | -- | -- | -- | $0 |
| **Total Current Liabilities** | $27.39M | $12.69M | $7.05M | $9.00M | $10.93M | $14.71M | $20.07M | $37.53M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $1.73M |
| Deferred Revenue (Non-Current) | $22K | $45K | $67K | $89K | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $52.13M | $69.33M | $56.84M | $64.28M | $2.54M | $1.04M | $1.16M | $3.01M |
| **Total Liabilities** | $79.52M | $82.02M | $63.89M | $73.27M | $13.47M | $15.76M | $21.23M | $40.54M |
| **Total Debt (incl. Leases)** | $1.57M | $1.69M | $1.80M | $1.90M | $6.23M | $7.40M | $10.01M | $12.60M |
| Common Stock | $786K | $761K | $733K | $550K | $550K | $549K | $493K | $469K |
| Retained Earnings | -$300.0M | -$278.2M | -$239.2M | -$230.4M | -$200.9M | -$189.6M | -$184.8M | -$192.2M |
| **Total Stockholders' Equity** | $131.6M | $126.1M | $138.0M | $51.92M | $80.12M | $90.21M | $74.67M | $66.33M |
| Total Equity | $131.6M | $126.1M | $138.0M | $51.92M | $80.12M | $90.21M | $74.67M | $66.33M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$38.18M | -$55.18M | -$37.94M | -$18.79M | -$36.12M | -$17.68M |
| Depreciation & Amortization | $845K | $990K | $960K | $778K | $232K | $91K |
| Stock-Based Compensation | $3.82M | $5.31M | $3.09M | $2.31M | $2.96M | $2.11M |
| Change in Payables | $802K | -$185K | $45K | -$1.21M | $669K | $289K |
| **Operating Cash Flow** | -$38.31M | -$27.02M | -$34.24M | -$31.42M | -$22.22M | -$9.07M |
| Capital Expenditure | -$587K | -$16K | -$457K | -$1.30M | -$1.83M | -$1.48M |
| **Free Cash Flow** | -$38.90M | -$27.04M | -$34.70M | -$32.72M | -$24.05M | -$10.55M |
| Purchases of Investments | -- | -- | -- | -- | -- | -$6.0K |
| **Investing Cash Flow** | -$560K | -$16K | -$280K | -$1.30M | -$1.83M | $38.45M |
| **Financing Cash Flow** | $56.10M | $94.28M | -$121K | $19.97M | $71.80M | $490K |
| **Net Change in Cash** | $17.23M | $67.24M | -$34.65M | -$12.74M | $47.75M | $29.87M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.87M | -$38.91M | -$8.86M | -$46.87M | $6.10M | -$4.80M | $7.38M | -$14.07M |
| Depreciation & Amortization | $200K | $200K | $149K | $163K | $200K | $200K | $245K | $245K |
| Stock-Based Compensation | $2.65M | $2.86M | $1.45M | $1.29M | $1.16M | $1.05M | $314K | $1.24M |
| Change in Payables | -$2.58M | $2.38M | $1.70M | $33K | -$744K | $1.01M | $507K | -$56K |
| **Operating Cash Flow** | -$23.12M | -$17.18M | -$18.04M | -$10.57M | -$10.24M | -$8.89M | -$8.62M | -$5.81M |
| Capital Expenditure | -$141K | -$69K | -$675K | -$409K | -$144K | -$31K | -$3.0K | -$3.0K |
| **Free Cash Flow** | -$23.26M | -$17.25M | -$18.71M | -$10.98M | -$10.38M | -$8.92M | -$8.62M | -$5.82M |
| **Investing Cash Flow** | -$141K | -$69K | -$675K | -$409K | -$117K | -$31K | -$3.0K | -$3.0K |
| Common Stock Issued | -- | -- | -- | -- | $0 | $4.65M | $384K | -- |
| **Financing Cash Flow** | $24.81M | $23.98M | $93.81M | $43.90M | -$3.37M | $17.44M | -$1.87M | $91.91M |
| **Net Change in Cash** | $1.55M | $6.73M | $75.10M | $32.92M | -$13.72M | $8.52M | -$10.49M | $86.10M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -27777.6% | -20580.8% | -11048.0% |
| **Net Profit Margin** | -- | -- | -- | -15035.2% | -28899.2% | -14144.0% |
| Return on Equity (ROE) | -73.5% | -83.2% | -297.7% | -39.4% | -56.3% | -- |
| Return on Assets (ROA) | -30.5% | -51.6% | -92.1% | -24.2% | -40.5% | -46.2% |
| Current Ratio | 13.49x | 2.77x | 2.59x | 12.81x | 15.84x | 7.46x |
| Quick Ratio | 13.31x | 2.74x | 2.50x | 12.48x | 15.41x | 7.44x |
| Debt to Equity | 0.04x | 0.19x | 1.73x | 0.04x | 0.01x | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | 0.0% | 0.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -75.3% | -70.2% | -39.4% | -73.5% | -28.4% | -24.5% | -53.0% | -83.2% |
| Return on Assets (ROA) | -47.0% | -42.5% | -27.0% | -30.5% | -24.3% | -20.9% | -41.3% | -51.6% |
| Current Ratio | 7.57x | 16.09x | 28.05x | 13.49x | 8.25x | 7.04x | 4.64x | 2.77x |
| Quick Ratio | 7.42x | 15.89x | 27.63x | 13.31x | 7.96x | 6.84x | 4.59x | 2.74x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.04x | 0.08x | 0.08x | 0.13x | 0.19x |
| **Net Income Growth (YoY)** | -- | -- | -220.1% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -193.3% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
